Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-02-25 @ 7:02 PM
Study NCT ID:
NCT02101268
Status:
COMPLETED
Last Update Posted:
2023-05-23
First Post:
2014-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF
Sponsor:
Sierra Oncology LLC - a GSK company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-28
First Submit QC Date:
None
Study First Post Date:
2014-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-02-23
Results First Submit QC Date:
None
Results First Post Date:
2023-05-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-02-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-05-10
Last Update Post Date:
2023-05-23
Last Update Post Date Type:
ACTUAL